Translation of "Residual toxicity " (English → French) :

residual effectiveness | residual toxicity

National Registry of Toxic Chemical Residues

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

toxicity study to determine the safety of orally administered residues

active principle | active toxic ingredient | active ingredient | A.I. | pure toxic ingredient | toxic ingredient | pure toxic substance | toxic substance | toxicant

subacute toxicity [ subchronic toxicity | short-term toxicity ]

poisonous material | poisonous substance | toxic chemical | toxic substance | toxicant

maximum residue limit [ MRL | maximum residue level | tolerable permissible residue | residue tolerance ]

Definition: Personality change, persisting for at least two years, attributable to the traumatic experience of suffering from a severe psychiatric illness. The change cannot be explained by a previous personality disorder and should be differentiated from residual schizophrenia and other states of incomplete recovery from an antecedent mental disorder. This disorder is characterized by an excessive dependence on and a demanding attitude towards others; conviction of being changed or stigmatized by the illness, leading to an inability to form and maintain close and confiding personal relationships and to social iso-lation; passivity, re ...[+++]duced interests, and diminished involvement in leisure activities; persistent complaints of being ill, which may be associated with hypochondriacal claims and illness behaviour; dysphoric or labile mood, not due to the presence of a current mental disorder or antecedent mental disorder with residual affective symptoms; and longstanding problems in social and occupational functioning.

Exophthalmic or toxic goitre NOS Graves' disease Toxic diffuse goitre

In summary, the main toxicological concerns that have been raised with respect to the use of rBST are: (a) would rBST residues be absorbed intact from the gastrointestinal tract in sufficient quantities to produce a toxic and/or immunologic response; and (b) would IGF1 residues in milk or milk products survive the gastrointestinal tract environment to produce localized effects, or be absorbed intact and remain bioactive in sufficient quantities to produce systemic effects?

Areas that were improved included the application of virtual elimination, clarification on pollution prevention planning, the adoption of the international definition of the precautionary principle, the use of toxic substances, the issue of residual powers, and the concept of inherent toxicity.

Improvements in the bill that were made with respect to virtual elimination, pollution prevention planning, the precautionary principle, the use of toxic substances, residual powers and inherent toxicity need to be supported by the Senate and seen as a starting point for consideration for further improving the bill.

Kinetics (pharmacokinetics, toxicokinetics, residue depletion) if toxicokinetics is performed as part of the regulatory repeat dose toxicity study, it should be reported under repeated dose toxicity.